A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...
InoPd with inobrodib 20 mg previously demonstrated response rates at least 2x greater than alternatives for heavily pretreated pomalidomide-refractory patients following bispecific T cell engager or ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple ...
Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma1 Milestone is a testament to ten years of daratumumab experience and innovation ...
With optimal treatment, myeloma isn't immediately life-threatening. Many patients live for years after their diagnosis, often ...
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based ...
Richardson, MD, gave an overview of the ways that CELMoDs are poised to impact the landscape of multiple myeloma treatment at various stages of disease treatment. At the Miami Cancer Institute’s ...
Health Secretary Robert F. Kennedy Jr. recently said that the diet could “cure” schizophrenia. We asked experts about the ...
A closely watched barometer for used vehicle pricing jumped last month. Cox Automotive on Friday reported its Manheim Used Vehicle Value Index — which tracks prices of used vehicles sold at its U.S.
Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilize, and test millions of potential drug molecules inside living cells, making it ...
Veterans and others who have suffered trauma and injuries are flocking to clinics around the world to take ibogaine. My own reason was deeply personal. Credit...Illustration By Melissa Santamaría ...